These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 8388496

  • 41. An Epstein-Barr virus isolated from a lymphoblastoid cell line has a 16-kilobase-pair deletion which includes gp350 and the Epstein-Barr virus nuclear antigen 3A.
    Lee W, Hwang YH, Lee SK, Subramanian C, Robertson ES.
    J Virol; 2001 Sep; 75(18):8556-68. PubMed ID: 11507201
    [Abstract] [Full Text] [Related]

  • 42. Visualization of alternative Epstein-Barr virus expression programs by fluorescent in situ hybridization at the cell level.
    Szeles A, Falk KI, Imreh S, Klein G.
    J Virol; 1999 Jun; 73(6):5064-9. PubMed ID: 10233969
    [Abstract] [Full Text] [Related]

  • 43. Epstein-Barr virus genotypes in NPC biopsies from north Africa.
    Bouzid M, Djennaoui D, Dubreuil J, Bouguermouh A, Ellouz D, Abdelwahab J, Decaussin G, Ooka T.
    Int J Cancer; 1994 Feb 15; 56(4):468-73. PubMed ID: 7906677
    [Abstract] [Full Text] [Related]

  • 44. Methylation of discrete sites within the enhancer region regulates the activity of the Epstein-Barr virus BamHI W promoter in Burkitt lymphoma lines.
    Jansson A, Masucci M, Rymo L.
    J Virol; 1992 Jan 15; 66(1):62-9. PubMed ID: 1370095
    [Abstract] [Full Text] [Related]

  • 45. Epstein-Barr virus encoded BALF1 gene is transcribed in Burkitt's lymphoma cell lines and in nasopharyngeal carcinoma's biopsies.
    Cabras G, Decaussin G, Zeng Y, Djennaoui D, Melouli H, Broully P, Bouguermouh AM, Ooka T.
    J Clin Virol; 2005 Sep 15; 34(1):26-34. PubMed ID: 16087121
    [Abstract] [Full Text] [Related]

  • 46. No role for Epstein-Barr virus in Dutch hepatocellular carcinoma: a study at the DNA, RNA and protein levels.
    Zur Hausen A, van Beek J, Bloemena E, Ten Kate FJ, Meijer CJLM, van den Brule AJC.
    J Gen Virol; 2003 Jul 15; 84(Pt 7):1863-1869. PubMed ID: 12810881
    [Abstract] [Full Text] [Related]

  • 47. Mapping of genes in BamHI fragment M of Epstein-Barr virus DNA that may determine the fate of viral infection.
    Sample J, Lancz G, Nonoyama M.
    J Virol; 1986 Jan 15; 57(1):145-54. PubMed ID: 2867227
    [Abstract] [Full Text] [Related]

  • 48. Viral and cellular factors influence the activity of the Epstein-Barr virus BCR2 and BWR1 promoters in cells of different phenotype.
    Nilsson T, Sjöblom A, Masucci MG, Rymo L.
    Virology; 1993 Apr 15; 193(2):774-85. PubMed ID: 8384755
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. In vivo transcription of the Epstein-Barr virus (EBV) BamHI-A region without associated in vivo BARF0 protein expression in multiple EBV-associated disorders.
    van Beek J, Brink AATP, Vervoort MBHJ, van Zijp MJM, Meijer CJLM, van den Brule AJC, Middeldorp JM.
    J Gen Virol; 2003 Oct 15; 84(Pt 10):2647-2659. PubMed ID: 13679598
    [Abstract] [Full Text] [Related]

  • 51. An Epstein-Barr virus with a 58-kilobase-pair deletion that includes BARF0 transforms B lymphocytes in vitro.
    Robertson ES, Tomkinson B, Kieff E.
    J Virol; 1994 Mar 15; 68(3):1449-58. PubMed ID: 8107208
    [Abstract] [Full Text] [Related]

  • 52. High-resolution analysis of CpG methylation and in vivo protein-DNA interactions at the alternative Epstein-Barr virus latency promoters Qp and Cp in the nasopharyngeal carcinoma cell line C666-1.
    Bakos A, Banati F, Koroknai A, Takacs M, Salamon D, Minarovits-Kormuta S, Schwarzmann F, Wolf H, Niller HH, Minarovits J.
    Virus Genes; 2007 Oct 15; 35(2):195-202. PubMed ID: 17510783
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Association of Epstein-Barr virus, human papilloma virus, and cytomegalovirus with nine nasopharyngeal carcinoma cell lines.
    Lin CT, Dee AN, Chen W, Chan WY.
    Lab Invest; 1994 Nov 15; 71(5):731-6. PubMed ID: 7967524
    [Abstract] [Full Text] [Related]

  • 55. Epstein-Barr virus RNA. V. Viral RNA in a restringently infected, growth-transformed cell line.
    King W, Thomas-Powell AL, Raab-Traub N, Hawke M, Kieff E.
    J Virol; 1980 Nov 15; 36(2):506-18. PubMed ID: 6253674
    [Abstract] [Full Text] [Related]

  • 56. EBNA-2 transactivates a lymphoid-specific enhancer in the BamHI C promoter of Epstein-Barr virus.
    Sung NS, Kenney S, Gutsch D, Pagano JS.
    J Virol; 1991 May 15; 65(5):2164-9. PubMed ID: 1850003
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Undifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx. Variants of Epstein-Barr virus-infected neoplasia.
    Pathmanathan R, Prasad U, Chandrika G, Sadler R, Flynn K, Raab-Traub N.
    Am J Pathol; 1995 Jun 15; 146(6):1355-67. PubMed ID: 7778675
    [Abstract] [Full Text] [Related]

  • 60. Discovery of Epstein-Barr virus (EBV)-encoded RNA signal and EBV nuclear antigen leader protein DNA sequence in pet dogs.
    Chiou SH, Chow KC, Yang CH, Chiang SF, Lin CH.
    J Gen Virol; 2005 Apr 15; 86(Pt 4):899-905. PubMed ID: 15784884
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.